Source: British Journal of Pharmacology. Unidades: IFSC, IQSC, FMRP
Subjects: DOENÇA DE CHAGAS (TRATAMENTO), INIBIDORES DE ENZIMAS, QUÍMICA INORGÂNICA, QUÍMICA MÉDICA, RUTÊNIO, FÁRMACOS, TRYPANOSOMA CRUZI
ABNT
SILVA, Jean Jerley Nogueira da et al. Novel ruthenium complexes as potential drugs for Chagas´s disease: enzyme inhibition and in vitro/in vivo trypanocidal activity. British Journal of Pharmacology, v. 160, n. 2, p. 260-269, 2010Tradução . . Disponível em: https://doi.org/10.1111/j.1476-5381.2010.00662.x. Acesso em: 14 nov. 2024.APA
Silva, J. J. N. da, Guedes, P. M. M., Zottis, A., Balliano, T. L., Silva, F. O. N., Lopes, L. G. F., et al. (2010). Novel ruthenium complexes as potential drugs for Chagas´s disease: enzyme inhibition and in vitro/in vivo trypanocidal activity. British Journal of Pharmacology, 160( 2), 260-269. doi:10.1111/j.1476-5381.2010.00662.xNLM
Silva JJN da, Guedes PMM, Zottis A, Balliano TL, Silva FON, Lopes LGF, Ellena J, Oliva G, Andricopulo AD, Franco DW, Silva JS da. Novel ruthenium complexes as potential drugs for Chagas´s disease: enzyme inhibition and in vitro/in vivo trypanocidal activity [Internet]. British Journal of Pharmacology. 2010 ; 160( 2): 260-269.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1111/j.1476-5381.2010.00662.xVancouver
Silva JJN da, Guedes PMM, Zottis A, Balliano TL, Silva FON, Lopes LGF, Ellena J, Oliva G, Andricopulo AD, Franco DW, Silva JS da. Novel ruthenium complexes as potential drugs for Chagas´s disease: enzyme inhibition and in vitro/in vivo trypanocidal activity [Internet]. British Journal of Pharmacology. 2010 ; 160( 2): 260-269.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1111/j.1476-5381.2010.00662.x